National Research's 15-minute chart has exhibited Bollinger Bands Expanding Upward and Bullish Marubozu patterns on September 3, 2025 at 11:30. This indicates that the market trend is being predominantly driven by buying pressure, with buyers in control of market direction. Consequently, there is a high likelihood that bullish momentum will persist.
Pineapple Financial, a NYSE American-listed fintech firm, has made a significant move in the cryptocurrency landscape by launching a $100 million fund to acquire Injective (INJ) tokens. This marks the first time a publicly listed company has held INJ tokens, positioning Pineapple Financial at the forefront of corporate crypto adoption [1].
The treasury aims to generate around 12% annual yield through staking, making it one of the most lucrative treasury allocations across blockchain networks. According to Eric Chen, co-founder of Injective, this launch represents a defining moment for Injective and its ecosystem [1].
The news comes as Injective gains further institutional traction. The SEC is currently reviewing Canary Capital’s staked INJ ETF application, which was filed in July 2025. This product is open for public comment and up to 90 days of review, indicating growing interest from institutional investors [1].
The announcement has had a positive impact on INJ's price, with the token jumping 7% to $13.2. Technical analysis suggests that INJ could rally toward $15.5 resistance, but a failure to hold $12.0 could trigger further retracement [1].
Meanwhile, the US regulatory stance around cryptocurrencies has improved since Trump’s second-term presidency, leading to a wave of fresh crypto treasury adoption. For instance, Strategy (MSTR) has seen its stock price rise by 2,300% since it began buying BTC in 2020, while Sharplink Gaming holds 797,000 ETH and Bitmine's latest acquisitions bring its total Ethereum holdings to 1.8 million ETH [1].
References:
[1] https://www.coinspeaker.com/pineapple-financial-launches-first-corporate-injective-inj-treasury-with-100m-investment/?prefer_reader_view=1&prefer_safari=1
[2] https://www.nasdaq.com/articles/national-research-appoints-shane-harrison-evp-and-cfo
Comments
No comments yet